Bhatia is Woodstock’s first CSO and will lead new product development for the company
Woodstock, IL, August 8, 2022 – Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), announced today that it has named Dr. Kuljit Bhatia as the company’s first Chief Scientific Officer. In this newly created role, Bhatia will lead the company’s New Product Development department, and is part of the organization’s senior staff.
“I am excited to add to Woodstock Sterile Solutions’ technical and scientific expertise by adding Dr. Bhatia to our team,” says Paul Josephs, Chief Executive Officer at Woodstock Sterile Solutions. “As we build on to the capabilities of our new Quality Control laboratory, Dr. Bhatia will serve as the strategic lead on expanding our development services, which we believe will help to drive long-term growth and value for the organization. I am confident that he will be a success in this new role.”
Dr. Bhatia joins Woodstock from Viatris, where he served as the Head of Global Dermatologics Scientific Affairs. He has more than 25 years of experience in drug product development, having also held leadership roles at Mylan, DPT Laboratories, Nycomed/Fougera Pharmaceuticals and Medicis. Dr. Bhatia earned his bachelor’s degree in Pharmacy and his doctorate in Pharmaceutical Science from North Dakota State University. He conducted post doctorate studies in Pharmaceuticals at the University of Michigan.
“There is a tremendous amount of opportunity for growth in advanced aseptic manufacturing and blow-fill-seal (BFS) technology, as the development of new drugs has become increasingly complex. Woodstock Sterile Solutions has worked for decades to advance this technology, and I look forward to helping the organization continue to build on its great reputation as an innovator and problem solver in the industry,” says Dr. Bhatia.
For more information on Woodstock Sterile Solutions, visit https://woodstocksterilesolutions.com.
About Woodstock Sterile Solutions
For 50 years, Woodstock Sterile Solutions has been recognized as a leading Blow-Fill-Seal (BFS) Contract Development and Manufacturing Organization (CDMO). We develop and supply BFS products for pharmaceutical and healthcare companies, providing best-in-class sterile development manufacturing solutions across a broad – and growing – range of applications, including respiratory, ophthalmic, topical, otic, and oral. As a highly focused organization, our expertise and commitment to innovation allow us to reduce development times and efficiently support our customers’ ability to deliver products to market. At Woodstock Sterile Solutions, we see a patient, family member or friend in every product we make and our goal is to be the best development and commercial partner in the industry, delivering life-enhancing molecules from the benchtop to the patient.